CCR5 and its ligands, particularly CCL5 have been thought to support tumor growth either directly, by driving the migration of tumor cells to tumor sites, and mostly by recruiting MDSC and dendritic cells to the tumor site [96,97,98,99,100]. The gene discussed is CCL5; the disease is neoplasm.